Large Granular Lymphocyte Leukemia: Clinical Trials

1 trial for Large Granular Lymphocyte Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Large Granular Lymphocyte Leukemia: new trials by email Literature Review of Large Granular Lymphocyte Leukemia trials Research Report on Large Granular Lymphocyte Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
JAK1 Inhibitor - Lymphoma, T-Cell, NK-LGL Leukemia
Phase 2RecruitingInstitute of Hematology & Blood Diseases Hospital, China482024-12-252025-11-18

Narrower conditions

Leukemia, Large Granular Lymphocytic (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Mycosis Fungoides (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, T-Cell (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (1)

Countries

China (1)